Literature DB >> 31991415

White Matter Brain Development after Exposure to Circulating Cell-Free Hemoglobin and Hyperoxia in a Rat Pup Model.

Åsa Jungner1, Suvi Vallius Kvist2, Olga Romantsik3, Matteo Bruschettini2, Claes Ekström2, Ivo Bendix4, Josephine Herz4, Ursula Felderhoff-Mueser4, Adnan Bibic5, René In Apos T Zandt5, Magnus Gram2, David Ley3.   

Abstract

Neonates born with critical congenital heart defects are at risk of diffuse white matter injuries and neurodevelopmental impairments. This study aimed to determine the impact of circulating cell-free hemoglobin and hyperoxia, both present during cardiopulmonary bypass circulation, on white matter brain development. Postnatal day 6 rat pups were injected intraperitoneally with cell-free Hb or vehicle and exposed to hyperoxia (fiO2 = 0.8) or normoxia (fiO2 = 0.21) for 24 h. We evaluated apoptosis, myelination, and oligodendrocyte maturation with immunohistochemistry, gene and protein analyses, and in vivo diffusion tensor magnetic resonance imaging (MRI). Consistent with previous studies, we found an increase in apoptosis of oligodendrocytes as determined by TUNEL+ staining in Olig2+ cells in white matter, cortex, thalamus, and hippocampus following exposure to hyperoxia with no additional effect of cell-free Hb. A transient increase in the mRNA expression of intercellular adhesion molecule 1 at 6 h was observed following combined exposure to cell-free Hb and hyperoxia. No indications of oligodendrocyte maturational delay or hypomyelination were observed after either insult, delivered separately or combined, as determined by immunohistochemistry, Western blot, and diffusion tensor MRI. In our model, exposure to circulatory cell-free Hb, with or without concomitant hyperoxia, did not significantly alter brain white matter development.
© 2020 S. Karger AG, Basel.

Entities:  

Keywords:  Cardiopulmonary bypass; Cell-free hemoglobin; Hyperoxia; Oligodendrocyte; White matter

Mesh:

Substances:

Year:  2020        PMID: 31991415      PMCID: PMC7212701          DOI: 10.1159/000505206

Source DB:  PubMed          Journal:  Dev Neurosci        ISSN: 0378-5866            Impact factor:   2.984


  33 in total

Review 1.  Hyperoxia and the Immature Brain.

Authors:  Bettina Reich; Daniela Hoeber; Ivo Bendix; Ursula Felderhoff-Mueser
Journal:  Dev Neurosci       Date:  2017-02-03       Impact factor: 2.984

2.  Microstructural and physiological features of tissues elucidated by quantitative-diffusion-tensor MRI.

Authors:  P J Basser; C Pierpaoli
Journal:  J Magn Reson B       Date:  1996-06

3.  Neonatal Immune Challenge with Lipopolysaccharide Triggers Long-lasting Sex- and Age-related Behavioral and Immune/Neurotrophic Alterations in Mice: Relevance to Autism Spectrum Disorders.

Authors:  Charllyany Sabino Custódio; Bruna Stefânia Ferreira Mello; Adriano José Maia Chaves Filho; Camila Nayane de Carvalho Lima; Rafaela Carneiro Cordeiro; Fábio Miyajima; Gislaine Z Réus; Silvânia Maria Mendes Vasconcelos; Tatiana Barichello; João Quevedo; Antônio Carlos de Oliveira; David Freitas de Lucena; Danielle S Macedo
Journal:  Mol Neurobiol       Date:  2017-05-23       Impact factor: 5.590

4.  Blood-brain barrier disruption and oxidative stress in guinea pig after systemic exposure to modified cell-free hemoglobin.

Authors:  Omer I Butt; Paul W Buehler; Felice D'Agnillo
Journal:  Am J Pathol       Date:  2011-03       Impact factor: 4.307

5.  New white matter brain injury after infant heart surgery is associated with diagnostic group and the use of circulatory arrest.

Authors:  John Beca; Julia K Gunn; Lee Coleman; Ayton Hope; Peter W Reed; Rodney W Hunt; Kirsten Finucane; Christian Brizard; Brieana Dance; Lara S Shekerdemian
Journal:  Circulation       Date:  2013-01-31       Impact factor: 29.690

6.  Anaesthetic neurotoxicity and neuroplasticity: an expert group report and statement based on the BJA Salzburg Seminar.

Authors:  V Jevtovic-Todorovic; A R Absalom; K Blomgren; A Brambrink; G Crosby; D J Culley; G Fiskum; R G Giffard; K F Herold; A W Loepke; D Ma; B A Orser; E Planel; W Slikker; S G Soriano; G Stratmann; L Vutskits; Z Xie; H C Hemmings
Journal:  Br J Anaesth       Date:  2013-05-30       Impact factor: 9.166

7.  Spatiotemporal dysfunction of the vascular permeability barrier in transgenic mice with sickle cell disease.

Authors:  Samit Ghosh; Fang Tan; Solomon F Ofori-Acquah
Journal:  Anemia       Date:  2012-06-12

8.  Effects of preoperative hypoxia on white matter injury associated with cardiopulmonary bypass in a rodent hypoxic and brain slice model.

Authors:  Kota Agematsu; Ludmila Korotcova; Joseph Scafidi; Vittorio Gallo; Richard A Jonas; Nobuyuki Ishibashi
Journal:  Pediatr Res       Date:  2014-01-31       Impact factor: 3.756

9.  Interaction of inflammation and hyperoxia in a rat model of neonatal white matter damage.

Authors:  Felix Brehmer; Ivo Bendix; Sebastian Prager; Yohan van de Looij; Barbara S Reinboth; Julia Zimmermanns; Gerald W Schlager; Daniela Brait; Marco Sifringer; Stefanie Endesfelder; Stéphane Sizonenko; Carina Mallard; Christoph Bührer; Ursula Felderhoff-Mueser; Bettina Gerstner
Journal:  PLoS One       Date:  2012-11-14       Impact factor: 3.240

10.  Improving basic and translational science by accounting for litter-to-litter variation in animal models.

Authors:  Stanley E Lazic; Laurent Essioux
Journal:  BMC Neurosci       Date:  2013-03-22       Impact factor: 3.288

View more
  2 in total

1.  Dynamic Changes of Endogenic or Exogenic β-Carboline Alkaloid Harmine in Different Mammals and Human in vivo at Developmental and Physiological States.

Authors:  Ning Cao; Shuping Li; Aimin Xu; Manlin Li; Xiaoguang Zou; Zunji Ke; Gang Deng; Xuemei Cheng; Changhong Wang
Journal:  Front Aging Neurosci       Date:  2022-01-14       Impact factor: 5.750

Review 2.  Perinatal Hyperoxia and Developmental Consequences on the Lung-Brain Axis.

Authors:  Stefanie Obst; Josephine Herz; Miguel A Alejandre Alcazar; Stefanie Endesfelder; Marius A Möbius; Mario Rüdiger; Ursula Felderhoff-Müser; Ivo Bendix
Journal:  Oxid Med Cell Longev       Date:  2022-02-24       Impact factor: 6.543

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.